The company aims to repurpose drugs by translating the mechanisms that allow hibernating animals to withstand the stresses of extended sleep.
The firm is using a microarray-based platform as part of a laboratory-based test to diagnose different types of stroke from blood samples.
The variant especially increases stroke risk among childhood cancer survivors who received an intermediate dose of radiation.
A University of California, Los Angeles-led team has found turning off the CCR5 gene could improve recovery after a stroke, according to Scientific American.
In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.
Data for nearly 306,500 individuals revealed the impact of independent lifestyle and genetic factors on stroke risk over roughly seven years of follow up.
Using data from the UK Biobank, researchers explored relative contributions that genetics and lifestyle make to cardiovascular disease and diabetes risk.
Data from almost 19,500 individuals did not show clear ties between a heterozygous mutation in the HBB hemoglobin beta gene and ischemic stroke risk.
In Nature this week: method that uses DNA methylation signatures to classify central nervous system tumors, and more.
The researchers uncovered more than 20 new stroke-associated genetic loci, some of which are the targets of antithrombotic drugs.
Russian CRISPR researcher moves along with plans to ultimately alter the genes of embryos of deaf couples, though awaits regulatory approval, Nature News reports.
University of California, San Francisco, researchers have uncovered a gene mutations that appears to make a father-son duo more efficient sleepers.
NPR reports a large health insurer has begun to cover some pharmacogenetic tests for psychiatric drugs.
In PLOS this week: genome-wide association study of non-syndromic orofacial cleft subtypes, epigenetic and transcriptomic analysis of pancreatic ductal adenocarcinoma, and more.